BB BIOTECH AG - 31 Dec 2024 SCHEDULE 13G/A Report for MacroGenics Inc Common Stock (MGNX)

Filing Manager: BB BIOTECH AG
Reporting Manager: BB Biotech AG
Security: MacroGenics Inc Common Stock
Symbol: MGNX
Shares outstanding: 62,847,867 shares
Disclosed Ownership: 9,929,963 shares
Ownership: 16%
Form type: SCHEDULE 13G/A
Filing time: 14 Feb 2025, 14:39:02 UTC
Date of event: 31 Dec 2024
Next filing: 13 Jun 2025
SEC: View on sec.gov

Reporting Managers (2)

Name	Ownership	Shares Owned	sole voting power	shared voting power	Signature	Title	CIK
BB Biotech AG	16%	9,929,963	0	9,929,963	/s/ Martin Gubler	Martin Gubler/Signatory Authority
Biotech Target N.V.	16%	9,929,963	0	9,929,963	/s/ Jan Bootsma	Jan Bootsma/Signatory Authority